akshay.janjalkar@gmail.com

Bata India Crosses 700 Franchise Stores, Expands Deep into Smaller Markets Bata India has achieved a significant milestone by crossing 700 franchise stores across the country, highlighting its strong expansion strategy and growing retail footprint. The company revealed that nearly 70% of its stores are now located in Tier II, III, and IV markets, reflecting […]

HUDCO Approves Interim Dividend, Sets Record Date and Borrowing Plan Housing & Urban Development Corporation Ltd (HUDCO) has announced key financial decisions, including the approval of its fourth interim dividend for the financial year. The company’s board has declared an interim dividend of ₹1.25 per equity share, reflecting its consistent commitment to rewarding shareholders. The

Larsen & Toubro May Partner with Chinese Firms Amid FDI Rule Relaxation Larsen & Toubro (L&T) has indicated that it may explore potential partnerships with Chinese companies following the relaxation of foreign direct investment (FDI) norms under Press Note 3. The company stated that competitiveness and cost efficiency will be key factors in evaluating any

Kirloskar Industries Resumes Operations at Solapur Plant After LPG Supply Stabilization Kirloskar Industries Limited has announced the resumption of operations at one of its high-pressure moulding lines at the Solapur plant, effective March 21. The production line had previously been impacted due to disruptions in LPG supply, which were linked to ongoing geopolitical tensions in

Alkem Labs Launches Affordable Semaglutide Injection in India Alkem Laboratories has announced the launch of its semaglutide injection in India, offering a significantly more affordable treatment option for patients with type 2 diabetes and obesity. The company stated that the weekly therapy cost will start at just ₹450, making it one of the most competitively

Torrent Pharma Launches Oral and Injectable Semaglutide in India Torrent Pharmaceuticals has announced the launch of both oral and injectable formulations of semaglutide in India, marking a significant milestone in the country’s diabetes and weight management treatment landscape. The company has become the first in India to introduce a generic version of oral semaglutide, expanding